Bank of America’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$769M Sell
4,909,938
-52,856
-1% -$7.92M 0.05% 316
2026
Q1
$758M Buy
4,962,794
+413,778
+9% +$63.4M 0.06% 307
2025
Q4
$627M Sell
4,549,016
-56,862
-1% -$7.45M 0.05% 349
2025
Q3
$591M Buy
4,605,878
+78,390
+2% +$9.57M 0.04% 390
2025
Q2
$548M Sell
4,527,488
-186,854
-4% -$21.1M 0.04% 400
2025
Q1
$526M Buy
4,714,342
+165,539
+4% +$17.6M 0.04% 391
2024
Q4
$443M Sell
4,548,803
-415,527
-8% -$44.3M 0.04% 418
2024
Q3
$571M Buy
4,964,330
+119,277
+2% +$13.5M 0.05% 379
2024
Q2
$516M Sell
4,845,053
-43,140
-0.9% -$4.33M 0.05% 370
2024
Q1
$473M Sell
4,888,193
-259,473
-5% -$26.6M 0.04% 388
2023
Q4
$520M Sell
5,147,666
-50,063
-1% -$4.83M 0.05% 332
2023
Q3
$529M Buy
5,197,729
+202,744
+4% +$20.6M 0.06% 308
2023
Q2
$504M Sell
4,994,985
-2,609,696
-34% -$261M 0.05% 318
2023
Q1
$700M Buy
7,604,681
+1,235,303
+19% +$108M 0.07% 263
2022
Q4
$578M Sell
6,369,378
-847,796
-12% -$71.4M 0.07% 284
2022
Q3
$549M Sell
7,217,174
-207,077
-3% -$17.2M 0.07% 287
2022
Q2
$628M Sell
7,424,251
-441,484
-6% -$38.7M 0.07% 260
2022
Q1
$690M Buy
7,865,735
+77,437
+1% +$6.7M 0.07% 269
2021
Q4
$681M Sell
7,788,298
-1,424,172
-15% -$118M 0.07% 287
2021
Q3
$753M Buy
9,212,470
+210,828
+2% +$19M 0.08% 243
2021
Q2
$821M Sell
9,001,642
-187,390
-2% -$16.7M 0.09% 220
2021
Q1
$785M Sell
9,189,032
-621,270
-6% -$55.8M 0.09% 218
2020
Q4
$926M Buy
9,810,302
+1,709,679
+21% +$149M 0.12% 174
2020
Q3
$704M Sell
8,100,623
-344,488
-4% -$29.8M 0.1% 200
2020
Q2
$738M Sell
8,445,111
-203,217
-2% -$17.5M 0.11% 183
2020
Q1
$713M Sell
8,648,328
-722,781
-8% -$64.5M 0.13% 163
2019
Q4
$887M Buy
9,371,109
+956,800
+11% +$85.9M 0.13% 175
2019
Q3
$731M Sell
8,414,309
-751,960
-8% -$67.5M 0.11% 192
2019
Q2
$837M Sell
9,166,269
-934,263
-9% -$79.1M 0.13% 170
2019
Q1
$870M Sell
10,100,532
-3,540
-0% -$284K 0.14% 163
2018
Q4
$777M Buy
10,104,072
+2,027,778
+25% +$158M 0.14% 166
2018
Q3
$624M Buy
8,076,294
+543,815
+7% +$40.2M 0.1% 216
2018
Q2
$510M Sell
7,532,479
-4,386
-0.1% -$303K 0.08% 247
2018
Q1
$546M Sell
7,536,865
-154,907
-2% -$11.8M 0.09% 225
2017
Q4
$579M Sell
7,691,772
-2,066,823
-21% -$156M 0.1% 225
2017
Q3
$751M Buy
9,758,595
+2,091,539
+27% +$158M 0.12% 184
2017
Q2
$573M Sell
7,667,056
-511,807
-6% -$36.3M 0.11% 195
2017
Q1
$544M Buy
8,178,863
+567,414
+7% +$37.8M 0.11% 195
2016
Q4
$497M Buy
7,611,449
+546,398
+8% +$35.4M 0.11% 210
2016
Q3
$500M Buy
7,065,051
+239,812
+4% +$17.5M 0.11% 200
2016
Q2
$505M Buy
6,825,239
+290,214
+4% +$20M 0.12% 188
2016
Q1
$424M Buy
6,535,025
+319,305
+5% +$21.7M 0.1% 210
2015
Q4
$479M Sell
6,215,720
-88,207
-1% -$7.01M 0.11% 201
2015
Q3
$519M Buy
6,303,927
+3,717,941
+144% +$331M 0.13% 180
2015
Q2
$228M Sell
2,585,986
-24,216
-0.9% -$2.22M 0.07% 295
2015
Q1
$231M Buy
2,610,202
+60,986
+2% +$5.41M 0.08% 277
2014
Q4
$212M Sell
2,549,216
-73,601
-3% -$6.1M 0.08% 294
2014
Q3
$221M Buy
2,622,817
+61,321
+2% +$4.96M 0.07% 287
2014
Q2
$208M Sell
2,561,496
-323,204
-11% -$25.4M 0.07% 309
2014
Q1
$220M Sell
2,884,700
-239,894
-8% -$17.5M 0.08% 254
2013
Q4
$225M Sell
3,124,594
-70,561
-2% -$4.9M 0.08% 256
2013
Q3
$220M Sell
3,195,155
-135,723
-4% -$8.98M 0.09% 232
2013
Q2
$211M Buy
+3,330,878
New +$217M 0.09% 208

Other funds holding NVS

Bank of America's NVS Position: Q2 2026 in Review

Bank of America reduced its Novartis (NVS) stake by 1.1% in Q2 2026, selling an estimated $7.92M and leaving 4,909,938 shares worth $769M. The position accounts for 0.05% of the portfolio, ranked #316.

Bank of America first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $926M in Q4 2020. 1,618 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Bank of America held 4,909,938 shares of Novartis worth $769M as of Q2 2026.
  • Bank of America sold 52,856 Novartis shares in Q2 2026, an estimated $7.92M.
  • Novartis made up 0.05% of Bank of America's portfolio in Q2 2026, its #316 holding.
  • Bank of America first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
  • Bank of America's Novartis position peaked at $926M in Q4 2020.
  • 1,618 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.